医学
相伴的
导管内乳头状粘液性肿瘤
癌症
肿瘤
放射科
普通外科
内科学
肿瘤科
病理
胰腺
作者
Hideko T. Oyama,Tsuyoshi Hamada,Yousuke Nakai,Mariko Tanaka,Kaoru Takagi,Ryosuke Fukuda,Ryunosuke Hakuta,Kazunaga Ishigaki,Setsuko Kanai,Yoshikuni Kawaguchi,Keisuke Kurihara,Hiroto Nishio,K. Noguchi,Tomotaka Saito,Tatsuya Shimoda,Tatsunori Suzuki,Yukari Suzuki,Shinya Takaoka,Shuichi Tange,Naminatsu Takahara,Kiyoshi Hasegawa,Tetsuo Ushiku,Mitsuhiro Fujishiro
出处
期刊:Annals of Surgery
[Ovid Technologies (Wolters Kluwer)]
日期:2024-03-20
标识
DOI:10.1097/sla.0000000000006268
摘要
Objective: To examine whether long-term surveillance of intraductal papillary mucinous neoplasms (IPMNs) leads to early diagnosis and better clinical outcomes of pancreatic ductal adenocarcinomas (PDACs) developing concomitantly with IPMNs. Summary Background Data: Long-term image-based surveillance is recommended for patients with low-risk IPMNs. However, it is unknown whether the surveillance can improve surgical and survival outcomes of patients with concomitant PDACs. Methods: Using a prospective single-institutional cohort of 4,620 patients with pancreatic cysts including 3,638 IPMN patients, we identified 63 patients who developed concomitant PDAC during long-term surveillance. We compared overall survival (OS) of 46 cases with concomitant PDAC to that of 460 matched cases diagnosed with non-IPMN-associated PDAC at the same institution. Multivariable hazard ratios and 95% confidence intervals (CIs) for overall mortality were computed using the Cox regression model with adjustment for potential confounders. Results: Concomitant PDACs were identified at an earlier cancer stage compared to non-IPMN-associated PDACs with 67% and 38% cases identified at stage 2 or earlier, respectively ( P <0.001) and 57% and 21% cases with R0 resection, respectively ( P <0.001). Compared to non-IPMN-associated PDACs, concomitant PDACs were associated with longer OS ( P =0.034) with a multivariable hazard ratio of 0.61 (95% CI, 0.39-0.96). The 5-year survival rate of patients with concomitant PDAC was higher compared to patients with non-IPMN-associated PDAC (34% vs. 18%, respectively; P =0.018). Conclusions: The surveillance for patients with IPMNs was associated with early identification of concomitant PDACs and longer survival of patients diagnosed with this malignancy.
科研通智能强力驱动
Strongly Powered by AbleSci AI